癌症是对异性线粒体的失败反应
1Department of Anesthesiology, State University of New York Downstate Health Sciences University, Brooklyn, NY, 11203, USA.
Experimental cell research
|August 22, 2025
概括
1948年西里尔·达林顿的癌症理论重点是线粒体之间的细胞内竞争. 这项研究表明一种潜在的癌症治疗方法涉及野生型线粒体及其基因.
科学领域:
- 细胞生物学
- 癌症学
- 遗传学
背景情况:
- 线粒体通常被称为细胞的"发电厂", 在细胞代谢和功能中起着至关重要的作用.
- 1948年西里尔·达林顿的"血基因理论"提出,癌症源于细胞内竞争,早于对线粒体的广泛理解.
- 最近的发现突显了线粒体的复杂作用和能力,
研究的目的:
- 在现代线粒体研究的背景下重新考虑Cyril Darlington的"血基因理论".
- 探索突变型和野生型线粒体之间的细胞内竞争是癌症的主要原因.
- 根据线粒体遗传学和功能提出潜在的癌症治疗策略.
主要方法:
- 历史科学文献的回顾,特别是西里尔·达林顿的"癌症起源的等离子体理论".
- 对线粒体遗传学,功能及其在癌症发展中的作用的当代研究进行分析.
- 正常和突变线粒体之间的细胞内竞争动态的理论建模.
主要成果:
- 达林顿的理论虽然没有直接引用线粒体,但与当前对线粒体在癌症中的作用的理解一致.
- 证据表明线粒体功能障碍和突变与各种癌症有关.
- 线粒体群体之间的细胞内竞争可能驱动瘤发生.
结论:
- 达林顿的"血基因理论"为了解癌症的起源提供了一个潜在的有效框架.
- 未来的癌症治疗可能涉及针对线粒体基因的治疗干预,并恢复野生类型的线粒体种群.
- 进一步研究线粒体遗传学及其在癌症中的作用对于开发新疗法至关重要.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K
Cancer
49.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.5K


